This announcement is a separate document:
迈普医学：华泰联合证券有限责任公司关于广州迈普再生医学科技股份有限公司2023年度内部控制自我评价报告的核查意见
Medprin Regenerative Medical Technologies: Huatai United Securities Co., Ltd. inspection opinions on the 2023 internal control self-evaluation report of Guangzhou Maipu Regenerative Medicine Technology Co., Ltd.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.